Versono
1 known investors
Versono is developing the ProSonic, an intravascular ultrasonic platform designed to cross complex peripheral chronic total occlusions (CTOs) before follow-on endovascular treatment, using axial and radial ultrasonic energy delivery. The technology targets treatment of vascular disease with high amputation rates and is investigational, not yet cleared by regulatory authorities.
Deep TechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Versono do?
- Versono is developing the ProSonic, an intravascular ultrasonic platform designed to cross complex peripheral chronic total occlusions (CTOs) before follow-on endovascular treatment, using axial and radial ultrasonic energy delivery. The technology targets treatment of vascular disease with high amputation rates and is investigational, not yet cleared by regulatory authorities.
- Who are Versono's investors?
- Versono's investors include Business Venture Partners.